保肾康联合厄贝沙坦治疗糖尿病肾病疗效观察

目的：观察保肾康联合厄贝沙坦治疗2型糖尿病肾病的疗效。方法：120例2型糖尿病肾病患者随机分为治疗组和对照组，每组各60例。在常规治疗的基础上，对照组应用厄贝沙坦治疗，治疗组应用保肾康与厄贝沙坦联合治疗，疗程均为12周。分别于治疗前、治疗后检测患者的血压、血糖、血脂和肾功能。结果：治疗组治疗后控制血糖、降低血压、调节血脂、降低尿蛋白和改善肾功能的情况明显优于对照组，治疗后各指标检测结果组间比较差异具有统计学意义（P＜0.01，P＜0.05）。结论：保肾康联合厄贝沙坦治疗糖尿病肾病能较好地改善和保护肾功能，且对糖尿病肾病患者血压、血糖、血脂也有良好的改善作用。

THERAPEUTIC EFFECTS OF BAOSHENKANG COMBINED IRBESARTAN FOR TREATING DIABETIC NEPHROPATHY

Objective：To observe the therapeutic effects of Baoshenkang combined irbesartan for treating type 2 diabetic nephropathy. Methods：120 type 2 diabetic nephropathy patients were randomly divided into treatment group and control group with 60 patients in each group. Besides regular treatment, the patients in control group were given irbesartan, patients in treatment group were given Baoshenkang combined irbesartan, all for 12 weeks. The blood pressure, blood glucose, blood lipid and renal function of patients were respectively detected before and after treatment. Results：After treatment, glucose control, lower blood pressure, regulating blood lipid and improving renal function of treatment group were obviously better than control group （P＆lt;0.01, P＆lt;0.05）.Conclusions：Treating diabetic nephropathy with Baoshenkang combined irbesartan can better improve and protect renal function;moreover, Baoshenkang combined irbesartan also has goodeffectsonimprovingbloodpressure,bloodglucose and blood lipid ofdiabetic nephropathy patients.